ROBERT HENNING: Open Payments
NPI 1285736611 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 72 payments from 15 companies in 2025. Trend: 2023 $1,794 · 2024 $1,895 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $236 |
| Novo Nordisk Inc | 5 | $205 |
| Novartis Pharmaceuticals Corporation | 11 | $167 |
| Amgen Inc. | 17 | $156 |
| Philips North America LLC | 5 | $151 |
| Merck Sharp & Dohme LLC | 5 | $116 |
| PFIZER INC. | 5 | $110 |
| Alnylam Pharmaceuticals Inc. | 4 | $92 |
| Boston Scientific Corporation | 2 | $56 |
| CVRx, Inc. | 1 | $43 |
Products named: Kerendia, REPATHA, LEQVIO, Ozempic, VYNDAQEL, ONPATTRO, VERQUVO, Wegovy.
Industry payments across FL — which companies pay providers there.
